Badshah, M. B.,
Vanar, V.,
Kandula, M.,
Kalva, N.,
Badshah, M. B.,
Revenur, V.,
Bechtold, M. L.,
Forcione, D. G.,
... Puli, S. R.
(2019).Peroral cholangioscopy with cholangioscopy-directed biopsies in the diagnosis of biliary malignancies: a systemic review and meta-analysis.European Journal of Gastroenterology and Hepatology,31(8), 935-940.
Den norske patologforening
(2012).Veileder i biopsibesvarelse av maligne svulster(2 utg.)Tromsø:DNP.
Gerges, C.,
Beyna, T.,
Tang, R. S. Y.,
Bahin, F.,
Lau, J. Y. W.,
van Geenen, E.,
Neuhaus, H.,
Nageshwar Reddy, D.,
& Ramchandani, M.
(2020).Digital single-operator peroral cholangioscopy-guided biopsy sampling versus ERCP-guided brushing for indeterminate biliary strictures: a prospective, randomized, multicenter trial (with video).Gastrointestinal Endoscopy,91(5), 1105-1113.
Liang, B.,
Zhong, L.,
He, Q.,
Wang, S.,
Pan, Z.,
Wang, T.,
& Zhao, Y.
(2015).Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis.Medical Science Monitor,21, 3555-63.
Saluja, S. S.,
Sharma, R.,
Pal, S.,
Sahni, P.,
& Chattopadhyay, T. K.
(2007).Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: a prospective study.HPB,9(5), 373-82.
Sasaki, M.,
Sato, Y.,
& Nakanuma, Y.
(2017).Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance.Histopathology,70(3), 423-434.
Sekretariatet for nye metoder
(25. november 2022).Retningslinje for bruk av nye legemidler før markedsføringstillatelse (compassionate use).
[nettressurs].
Hamar:
nyemetoder.no.Hentet 28. november 2022fra https://nyemetoder.no/om-systemet/retningslinje-for-bruk-av-nye-legemidler-for-markedsforingstillatelse-compassionate-use
Shibata, T.,
Arai, Y.,
& Totoki, Y.
(2018).Molecular genomic landscapes of hepatobiliary cancer.Cancer Science,109(5), 1282-1291.
Suthar, M.,
Purohit, S.,
Bhargav, V.,
& Goyal, P.
(2015).Role of MRCP in Differentiation of Benign and Malignant Causes of Biliary Obstruction.Journal of clinical and diagnostic research : JCDR,9(11), Tc08-12.
Tirotta, F.,
Giovinazzo, F.,
Hodson, J.,
Yates, L.,
Tan, D.,
Salsano, M.,
Baker, D.,
Sundareyan, R.,
... Sutcliffe, R.
(2020).Risk factors to differentiate between benign proximal biliary strictures and perihilar cholangiocarcinoma.HPB,22(12), 1753-1758.
Weber, S. M.,
Ribero, D.,
O'Reilly, E. M.,
Kokudo, N.,
Miyazaki, M.,
& Pawlik, T. M.
(2015).Intrahepatic cholangiocarcinoma: expert consensus statement.HPB,17(8), 669-80.
WHO Classification of Tumours Editorial Board
(2019).Digestive system Tumours(WHO Classification of Tumours, 5th Edition, Volume 1).Lyon:IARC.